Poor solubility and absorption of complex phytochemical compounds limit therapeutic efficacy. Overcoming these delivery barriers ensures consistent systemic exposure and clinical potency.

Low bioavailability or inadequate potency of raw botanical compounds limits their clinical utility. Enhancing therapeutic concentration enables the treatment of complex metabolic and oncological pathologies.

Insufficient cerebral blood flow and cognitive decline represent physiological failure modes. Addressing these deficits restores functional performance in aging or impaired biological systems.

Excessive postprandial glucose uptake and metabolic imbalances lead to chronic conditions like atherosclerosis. Regulating these absorption pathways mitigates systemic health degradation.